TURNER JOSEPH L 4
4 · Arcutis Biotherapeutics, Inc. · Filed Feb 3, 2020
Insider Transaction Report
Form 4
TURNER JOSEPH L
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-01-30+37,500→ 37,500 totalExercise: $17.00Exp: 2030-01-30→ Common Stock (37,500 underlying)
Footnotes (2)
- [F1]Stock options were granted to the Reporting Person on January 30, 2020 in connection with the Reporting Person's appointment to the Issuer's Board of Directors on January 30, 2020.
- [F2]The option vests as to 1/3 of the total shares on each of January 30, 2021, January 30, 2022 and January 30, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date.